Aenova will have a digital presence at the Animal Health Innovation USA conference.
The global animal health market was valued at USD 50 billion in 2020 and is expected to grow at a CAGR of 8.8% for the rest of the decade. The market is driven by an increase in diseases globally, which has triggered the production of vaccines and pharmaceuticals. The almost 800 million people worldwide who are undernourished has heightened the urgent need for expanded food supply through large-scale adoption of livestock. The Covid pandemic has also resulted in increased demand for companion animals as people have found themselves looking to combat loneliness in the wake of social distancing.
Aenova is the global CDMO leader in animal health, manufacturing millions of doses for both livestock and companion animals. Our development and manufacturing services cover many therapeutic categories such as oral antimicrobials, internal medicine, endoparasiticides, topicals and hormones.
Our capabilities include:
Penicillin Sterile (powder for injection, liquid vials, intramammary syringes)
Cephalosporin Sterile (powder for injection, intramammary syringes)
Penicillin Oral Solids
Oral Solids (conventional)
Oral Solids (parasiticides)
Our impeccable regulatory track record at 15 manufacturing facilities make us the partner of choice for your next outsourcing project.